Search Results - "Cayla, G."

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis by Silvain, Johanne, Beygui, Farzin, Barthélémy, Olivier, Pollack, Charles, Cohen, Marc, Zeymer, Uwe, Huber, Kurt, Goldstein, Patrick, Cayla, Guillaume, Collet, Jean-Philippe, Vicaut, Eric, Montalescot, Gilles

“…Objective To determine the efficacy and safety of enoxaparin compared with unfractionated heparin during percutaneous coronary intervention.Design Systematic…”
Get full text

High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study by SILVAIN, Johanne, CAYLA, Guillaume, MONTALESCOT, Gilles, HULOT, Jean-Sébastien, FINZI, Jonathan, KERNEIS, Mathieu, O'CONNOR, Stephen A, BELLEMAIN-APPAIX, Anne, BARTHELEMY, Olivier, BEYGUI, Farzin, COLLET, Jean-Philippe

“…The aim of this study was to compare on-thienopyridine platelet reactivity of elderly patients (≥75 years) vs. younger patients (<75 years). Elderly patients…”
Get full text

Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014-2019) by Mezier, A, Motreff, P, Clerc, J M, Bar, O, Deballon, R, Demicheli, T, Dechery, T, Souteyrand, G, Py, A, Lhoest, N, Lhermusier, T, Honton, B, Gommeaux, A, Jeanneteau, J, Deharo, P, Benamer, H, Cayla, G, Koning, R, Pereira, B, Collet, J P, Rangé, G

“…while the duration of dual antiplatelet therapy (DAPT) following coronary angioplasty for chronic coronary syndrome (CCS) recommended by the European Society…”
Get full text

Reliability of hemostasis biomarkers is affected by time‐dependent intra‐patient variability by Bouvier, S., Bastide, S., Chouirfa, S., Nouvellon, É., Mercier, É., Bigot, L., Lavigne, G., Cayla, G., Pérez‐Martin, A., Gris, J.‐C.

“…Essentials Nucleosomes and free DNA are two newly described biomarkers in venous thromboembolism (VTE). Reliability of nucleosomes, plasma free DNA and…”
Get full text

6′-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding by Powell, Katherine M., Brown, Alexa P., Skaggs, Cayla G., Pulliam, Alexis N., Berman, Alycia G., Deosthale, Padmini, Plotkin, Lilian I., Allen, Matthew R., Williams, David R., Wallace, Joseph M.

“…Raloxifene (RAL) is an FDA-approved drug used to treat osteoporosis in postmenopausal women. RAL suppresses bone loss primarily through its role as a selective…”
Get full text

Assessment of Patient's Peak Skin Dose Using Gafchromic Films During Interventional Cardiology Procedures: Routine Experience Feedback by Greffier, J, Moliner, G, Pereira, F, Cornillet, L, Ledermann, B, Schmutz, L, Lomma, M, Cayla, G, Beregi, J P

“…To assess the interest of Gafchromic films in detection of patient's peak skin dose (PSD) in interventional cardiology. A prospective study of 112 patients was…”
Get full text

Assessment of peak skin dose in interventional cardiology: A comparison between Gafchromic film and dosimetric software em.dose by Greffier, J, Van Ngoc Ty, C, Bonniaud, G, Moliner, G, Ledermann, B, Schmutz, L, Cornillet, L, Cayla, G, Beregi, J.P, Pereira, F

“…Highlights • Peak skin dose (PSD) may exceed 2 Gy during cardiac interventional procedures. • Gafchromic film is the most widely-used prospective technique to…”
Get full text

Long-term effectiveness and side effects of mandibular advancement devices on dental and skeletal parameters by Vigié du Cayla, G., Collet, J.M., Attali, V., Kerbrat, J.B., Benslama, L., Goudot, P.

“…Continuous positive airways pressure, generally used to treat obstructive sleep apnea-hypopnea syndrome (OSAHS), is not tolerated well by many patients. An…”
Get full text

Which patient for TAVI in 2019? by Cayla, G, Schmutz, L, Soullier, C, Ricci, J E, Robert, C, Cambon-Viala, M, Goger, A L, Lattuca, B

“…The therapeutic management of aortic stenosis has been drastically changed by the advent of percutaneous valve replacement (TAVI). Since the first…”
Get more information

stent thrombosis : A won battle ? (data from the France PCI registry) by Rangé, G, Hakim, R, Etienne, C Saint, Deballon, R, Dechery, T, Souteyrand, G, Bar, O, Albert, F, Canville, A, Gamet, A, Beygui, F, Viallard, L, Bonnet, P, Durand, E, Lesault, P-F, Boiffard, E, Koning, R, Benamer, H, Commeau, P, Cayla, G, Motreff, P

“…The aim of the study is to assess the incidence, risk factors and prognosis of definite stent thrombosis (ST) at 1 year in the France PCI multicenter…”
Get more information

Rehabilitation program for heart failure (guidelines and practical modalities) by Ledermann, B, Loscos, M, Robert, C, Cayla, G

“…Chronic Heart failure (CHF), a highly prevalent condition, is a major cause of morbidity and mortality, and generates significant costs. CHF causes a reduction…”
Get full text

Position paper of French Interventional Group (GACI) for TAVI in France in 2018 by Benamer, H., Auffret, V., Cayla, G., Chevalier, B., Dupouy, P., Eltchaninoff, H., Gilard, M., Guerin, P., Iung, B., Koning, R., Monsegu, J., Lantelme, P., Le Breton, H., Lefèvre, T., Verhoye, J.-P., Commeau, P., Motreff, P.

“…Aortic stenosis is a frequent disease in the elderly. Its prevalence is 0.4% with a sharp increase after the age of 65, and its outcome is very poor when the…”
Get full text

Providing Patients with Implantable Cardiac Device Data through a Personal Health Record: A Qualitative Study by Daley, Carly N, Chen, Elizabeth M, Roebuck, Amelia E, Ghahari, Romisa Rohani, Sami, Areej F, Skaggs, Cayla G, Carpenter, Maria D, Mirro, Michael J, Toscos, Tammy R

“…Background Patients at risk for sudden cardiac death or having suffered cardiac arrest may receive an implantable cardioverter defibrillator (ICD). This device…”
Get full text

Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study by Cayla, G, Silvain, J, Barthelemy, O, Connor, S 'O, Payot, L, Bellemain-Appaix, A, Beygui, F, Aout, M, Collet, J-P, Vicaut, E, Montalescot, G

“…To determine the incidence, type and possible association with mortality of major bleeding in patients with non-ST segment elevation acute coronary syndrome…”
Get more information

Platelet function testing to adjust antiplatelet therapy for elective coronary stenting: a landmark analysis of the ARCTIC trial by Montalescot, G., Range, G., Belle, L., Pouillot, C., Boueri, Z., Cayla, G., Van Belle, E., Silvain, J., Vicaut, E., Collet, J. P.

Get full text

Current antiplatelet options for NSTE-ACS patients by CAYLA, G, SILVAIN, J, O'CONNOR, S. A, COLLET, J.-P, MONTALESCOT, G

“…Non-ST elevation (NSTE) myocardial infarction and unstable angina are the most common clinical presentations of acute coronary syndrome (ACS). Platelet…”
Get full text

Optimal time for catheterization in NSTE-ACS patients with impaired renal function Insights from the ABOARD Study by BARTHELEMY, O, CAYLA, G, MONTALESCOT, G, SILVAIN, J, O'CONNOR, S. A, BELLEMAIN-APPAIX, A, BEYGUI, F, SIDERIS, G, VARENNE, O, COLLET, J. P, VICAUT, E

“…To assess the impact of impaired renal function (IRF) and timing of catheterization (immediate versus delayed intervention) on outcomes in intermediate/high…”
Get full text

Aspirin and clopidogrel resistance: should we worry about? by Cuisset, T, Cayla, G

“…Antiplatelet therapy is a cornerstone of coronary artery disease treatment and prevention. Aspirin and clopidogrel has emerged as the gold standard combination…”
Get more information

Optimal time for catheterization in NSTE-ACS patients with impaired renal function by Barthélémy, O, Cayla, G, Silvain, J, O'Connor, S.A, Bellemain-Appaix, A, Beygui, F, Sideris, G, Varenne, O, Collet, J.P, Vicaut, E, Montalescot, G

“…Abstract Background To assess the impact of impaired renal function (IRF) and timing of catheterization (immediate versus delayed intervention) on outcomes in…”
Get full text

Erratum to: Providing Patients with Implantable Cardiac Device Data through a Personal Health Record: A Qualitative Study by Daley, Carly N, Chen, Elizabeth M, Roebuck, Amelia E, Ghahari, Romisa Rohani, Sami, Areej F, Skaggs, Cayla G, Carpenter, Maria D, Mirro, Michael J, Toscos, Tammy R

Get full text